Company Ticker News December 23, 2021Biogen Inc. (BIIB) Gains But Lags Market: What You Should Know 0 0 Share
Company Ticker News December 22, 2021Japan regulator to continue deliberations on Biogen and Eisai's Alzheimer's drug 0 0 Share
Press Release December 22, 2021Japan's First Committee on New Drugs of The Pharmaceutical Affairs and Food Sanitation Council Seeks Additional Data; Aducanumab Remains under Review 0 0 Share
Company Ticker News December 20, 2021Biogen's decision to halve price of Alzheimer's drug is ‘a day late and a dollar short,' says Raymond James 0 0 Share
Company Ticker News December 20, 2021After Much Criticism, Biogen Slashes Aduhelm Price In Half 0 0 Share
Company Ticker News December 20, 2021Biogen to lower price of Alzheimer's drug aduhlem by 50% starting Jan. 1 to about $28,200 a year 0 0 Share
Press Release December 20, 2021Biogen Announces Reduced Price for ADUHELM® to Improve Access for Patients with Early Alzheimer's Disease 0 0 Share
